Rheumatoid Arthritis

Latest News

FDA approves tocilizumab-bavi as biosimilar for PJIA, SJIA in children 2 years and up | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves tocilizumab-bavi as biosimilar for PJIA, SJIA in children 2 years and up

October 2nd 2023

Tocilizumab-bavi (Tofidence; Biogen) demonstrated a biosimilarity to tocilizumab (Actemra; Genentech) based on multifaceted clinical and non-clinical data for polyarticular juvenile idiopathic arthritis (PJIA) and systemic juvenile idiopathic arthritis (sJIA) in children aged 2 years and up. This makes it the first tocilizumab biosimilar to be FDA-approved in the United States, according to Biogen.

Children with psoriasis, psoriatic arthritis experience heightened mood issues | Image Credit: © jaojormami - © jaojormami - stock.adobe.com.
Children with psoriasis, psoriatic arthritis experience heightened mood issues

July 31st 2023

More research needed on juvenile arthritis and exposure to maternal infection
More research needed on juvenile arthritis and exposure to maternal infection

July 11th 2022

Secukinumab receives expanded approvals in EU for pediatric arthritic conditions
Secukinumab receives expanded approvals in EU for pediatric arthritic conditions

July 5th 2022

RHEUMATOLOGY: Evaluating potential rheumatic diseases

November 1st 2013

Latest CME Events & Activities

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates

View More

Earn CME Credits While Advancing Your Expertise in Internal Medicine

April 18-19, 2024

Register Now!

The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis

View More

Advances In™ Schizophrenia: Expanding the Therapeutic Landscape

View More

Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Southern California Psychiatry Conference

September 13-14, 2024

Register Now!

Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency

View More

3rd Annual International Congress on Pediatric Oncology

October 25, 2024

View More

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder

View More

Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations

View More

5th Annual International Congress on the Future of Neurology®

View More

2023 Annual Psychiatric Times™ World CME Conference

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Advances In™ Rare Genetic Forms of Obesity: Emerging Therapeutic Targets

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Comprehensive Approaches to Creating Successful Sickle Cell Management Plans Across Patients’ Lifespans

View More

Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

View More

More News

© 2024 MJH Life Sciences

All rights reserved.